APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Doxepin Hydrochloride

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Doxepin Hydrochloride Industry Growth and Trends Forecast to 2032

Report ID 173985820119 December 2025101 pages

Choose your research edition.

Industry ResearchDoxepin Hydrochloride Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Doxepin Hydrochloride Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Doxepin Hydrochloride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Doxepin Hydrochloride Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Doxepin Hydrochloride Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Doxepin Hydrochloride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Doxepin Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Doxepin Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Doxepin Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Doxepin Hydrochloride include Ajanta Pharma, Amneal Pharms, Aurobindo Pharma, Boehringer Ingelheim, Elorac, Mylan Pharms, Par Pharm, Winston Pharmaceuticals and Hongsu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Doxepin Hydrochloride market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Doxepin Hydrochloride market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Doxepin Hydrochloride market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Doxepin Hydrochloride.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Doxepin Hydrochloride market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Doxepin Hydrochloride Market by Company

Ajanta Pharma

Amneal Pharms

Aurobindo Pharma

Boehringer Ingelheim

Elorac

Mylan Pharms

Par Pharm

Winston Pharmaceuticals

Hongsu Pharmaceutical

Qingping Pharmaceutical

Zhongxi Sunve Pharmaceutical

Doxepin Hydrochloride Segment by Type

10mg

25mg

50mg

Doxepin Hydrochloride Segment by Application

Major Depressive Disorder

Trouble Sleeping

Chronic Hives

Anxiety Disorders

Doxepin Hydrochloride Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Doxepin Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Doxepin Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Doxepin Hydrochloride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Doxepin Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Doxepin Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg Table 2. Major Company of 25mg Table 3. Major Company of 50mg Table 4. Global Doxepin Hydrochloride Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Doxepin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 6. Global Doxepin Hydrochloride Sales Market Share in Volume by Type (2021-2026) Table 7. Global Doxepin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 8. Global Doxepin Hydrochloride Sales Market Share in Value by Type (2021-2026) Table 9. Global Doxepin Hydrochloride Price by Type (2021-2026) & (US$/Unit) Table 10. Global Doxepin Hydrochloride Sales by Type (2027-2032) & (K Units) Table 11. Global Doxepin Hydrochloride Sales Market Share in Volume by Type (2027-2032) Table 12. Global Doxepin Hydrochloride Sales by Type (2027-2032) & (US$ Million) Table 13. Global Doxepin Hydrochloride Sales Market Share in Value by Type (2027-2032) Table 14. Global Doxepin Hydrochloride Price by Type (2027-2032) & (US$/Unit) Table 15. North America Doxepin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 16. North America Doxepin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Doxepin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 18. Europe Doxepin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Doxepin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Doxepin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Doxepin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 22. Latin America Doxepin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Doxepin Hydrochloride Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Doxepin Hydrochloride Sales by Type (2021-2026) & (US$ Million) Table 25. Doxepin Hydrochloride Industry Trends Table 26. Doxepin Hydrochloride Industry Drivers Table 27. Doxepin Hydrochloride Industry Opportunities and Challenges Table 28. Doxepin Hydrochloride Industry Restraints Table 29. Global Doxepin Hydrochloride Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Doxepin Hydrochloride Revenue Market Share by Company (2021-2026) Table 31. Global Doxepin Hydrochloride Sales by Company (2021-2026) & (K Units) Table 32. Global Doxepin Hydrochloride Sales Share by Company (2021-2026) Table 33. Global Doxepin Hydrochloride Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Doxepin Hydrochloride Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Doxepin Hydrochloride Major Company Production Sites and Headquarters Table 36. Global Doxepin Hydrochloride Company, Product Type & Application Table 37. Global Doxepin Hydrochloride Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Doxepin Hydrochloride by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Doxepin Hydrochloride Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Doxepin Hydrochloride Sales by Region (2021-2026) & (K Units) Table 42. Global Doxepin Hydrochloride Sales Market Share in Volume by Region (2021-2026) Table 43. Global Doxepin Hydrochloride Sales by Region (2021-2026) & (US$ Million) Table 44. Global Doxepin Hydrochloride Sales Market Share in Value by Region (2021-2026) Table 45. Global Doxepin Hydrochloride Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Doxepin Hydrochloride Sales by Region (2027-2032) & (K Units) Table 47. Global Doxepin Hydrochloride Sales Market Share in Volume by Region (2027-2032) Table 48. Global Doxepin Hydrochloride Sales by Region (2027-2032) & (US$ Million) Table 49. Global Doxepin Hydrochloride Sales Market Share in Value by Region (2027-2032) Table 50. Global Doxepin Hydrochloride Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Doxepin Hydrochloride Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Doxepin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 53. Global Doxepin Hydrochloride Sales Market Share in Volume by Application (2021-2026) Table 54. Global Doxepin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 55. Global Doxepin Hydrochloride Sales Market Share in Value by Application (2021-2026) Table 56. Global Doxepin Hydrochloride Price by Application (2021-2026) & (US$/Unit) Table 57. Global Doxepin Hydrochloride Sales by Application (2027-2032) & (K Units) Table 58. Global Doxepin Hydrochloride Sales Market Share in Volume by Application (2027-2032) Table 59. Global Doxepin Hydrochloride Sales by Application (2027-2032) & (US$ Million) Table 60. Global Doxepin Hydrochloride Sales Market Share in Value by Application (2027-2032) Table 61. Global Doxepin Hydrochloride Price by Application (2027-2032) & (US$/Unit) Table 62. North America Doxepin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 63. North America Doxepin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Doxepin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 65. Europe Doxepin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Doxepin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Doxepin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Doxepin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 69. Latin America Doxepin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Doxepin Hydrochloride Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Doxepin Hydrochloride Sales by Application (2021-2026) & (US$ Million) Table 72. Ajanta Pharma Company Information Table 73. Ajanta Pharma Business Overview Table 74. Ajanta Pharma Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Ajanta Pharma Doxepin Hydrochloride Product Portfolio Table 76. Ajanta Pharma Recent Development Table 77. Amneal Pharms Company Information Table 78. Amneal Pharms Business Overview Table 79. Amneal Pharms Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Amneal Pharms Doxepin Hydrochloride Product Portfolio Table 81. Amneal Pharms Recent Development Table 82. Aurobindo Pharma Company Information Table 83. Aurobindo Pharma Business Overview Table 84. Aurobindo Pharma Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Aurobindo Pharma Doxepin Hydrochloride Product Portfolio Table 86. Aurobindo Pharma Recent Development Table 87. Boehringer Ingelheim Company Information Table 88. Boehringer Ingelheim Business Overview Table 89. Boehringer Ingelheim Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Boehringer Ingelheim Doxepin Hydrochloride Product Portfolio Table 91. Boehringer Ingelheim Recent Development Table 92. Elorac Company Information Table 93. Elorac Business Overview Table 94. Elorac Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Elorac Doxepin Hydrochloride Product Portfolio Table 96. Elorac Recent Development Table 97. Mylan Pharms Company Information Table 98. Mylan Pharms Business Overview Table 99. Mylan Pharms Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Mylan Pharms Doxepin Hydrochloride Product Portfolio Table 101. Mylan Pharms Recent Development Table 102. Par Pharm Company Information Table 103. Par Pharm Business Overview Table 104. Par Pharm Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Par Pharm Doxepin Hydrochloride Product Portfolio Table 106. Par Pharm Recent Development Table 107. Winston Pharmaceuticals Company Information Table 108. Winston Pharmaceuticals Business Overview Table 109. Winston Pharmaceuticals Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Winston Pharmaceuticals Doxepin Hydrochloride Product Portfolio Table 111. Winston Pharmaceuticals Recent Development Table 112. Hongsu Pharmaceutical Company Information Table 113. Hongsu Pharmaceutical Business Overview Table 114. Hongsu Pharmaceutical Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Hongsu Pharmaceutical Doxepin Hydrochloride Product Portfolio Table 116. Hongsu Pharmaceutical Recent Development Table 117. Qingping Pharmaceutical Company Information Table 118. Qingping Pharmaceutical Business Overview Table 119. Qingping Pharmaceutical Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Qingping Pharmaceutical Doxepin Hydrochloride Product Portfolio Table 121. Qingping Pharmaceutical Recent Development Table 122. Zhongxi Sunve Pharmaceutical Company Information Table 123. Zhongxi Sunve Pharmaceutical Business Overview Table 124. Zhongxi Sunve Pharmaceutical Doxepin Hydrochloride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Zhongxi Sunve Pharmaceutical Doxepin Hydrochloride Product Portfolio Table 126. Zhongxi Sunve Pharmaceutical Recent Development Table 127. North America Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Doxepin Hydrochloride Sales by Country (2021-2026) & (K Units) Table 129. North America Doxepin Hydrochloride Sales Market Share by Country (2021-2026) Table 130. North America Doxepin Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Doxepin Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 132. North America Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Doxepin Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Doxepin Hydrochloride Market Share by Country (2021-2026) Table 135. North America Doxepin Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Doxepin Hydrochloride Market Share Forecast by Country (2027-2032) Table 137. Europe Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Doxepin Hydrochloride Sales by Country (2021-2026) & (K Units) Table 139. Europe Doxepin Hydrochloride Sales Market Share by Country (2021-2026) Table 140. Europe Doxepin Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Doxepin Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Doxepin Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Doxepin Hydrochloride Market Share by Country (2021-2026) Table 145. Europe Doxepin Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Doxepin Hydrochloride Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Doxepin Hydrochloride Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Doxepin Hydrochloride Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Doxepin Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Doxepin Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Doxepin Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Doxepin Hydrochloride Market Share by Country (2021-2026) Table 155. Asia-Pacific Doxepin Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Doxepin Hydrochloride Market Share Forecast by Country (2027-2032) Table 157. Latin America Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Doxepin Hydrochloride Sales by Country (2021-2026) & (K Units) Table 159. Latin America Doxepin Hydrochloride Sales Market Share by Country (2021-2026) Table 160. Latin America Doxepin Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Doxepin Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Doxepin Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Doxepin Hydrochloride Market Share by Country (2021-2026) Table 165. Latin America Doxepin Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Doxepin Hydrochloride Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Doxepin Hydrochloride Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Doxepin Hydrochloride Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Doxepin Hydrochloride Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Doxepin Hydrochloride Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Doxepin Hydrochloride Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Doxepin Hydrochloride Market Share by Country (2021-2026) Table 175. Middle East and Africa Doxepin Hydrochloride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Doxepin Hydrochloride Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Doxepin Hydrochloride Distributors List Table 180. Doxepin Hydrochloride Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Doxepin Hydrochloride Image Figure 2. Global Doxepin Hydrochloride Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Doxepin Hydrochloride Market Size (2021-2032) & (US$ Million) Figure 4. Global Doxepin Hydrochloride Sales (2021-2032) & (K Units) Figure 5. 10mg Image Figure 6. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 25mg Image Figure 8. Global 25mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 50mg Image Figure 10. Global 50mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Doxepin Hydrochloride Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Doxepin Hydrochloride Market Share by Type 2025 VS 2032 Figure 13. North America Doxepin Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 14. North America Doxepin Hydrochloride Sales Market Share in Value by Type in 2025 Figure 15. Europe Doxepin Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 16. Europe Doxepin Hydrochloride Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Doxepin Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Doxepin Hydrochloride Sales Market Share in Value by Type in 2025 Figure 19. Latin America Doxepin Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Doxepin Hydrochloride Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Doxepin Hydrochloride Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Doxepin Hydrochloride Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Doxepin Hydrochloride Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Major Depressive Disorder Image Figure 26. Global Major Depressive Disorder Sales YoY Growth (2021-2032) & (K Units) Figure 27. Trouble Sleeping Image Figure 28. Global Trouble Sleeping Sales YoY Growth (2021-2032) & (K Units) Figure 29. Chronic Hives Image Figure 30. Global Chronic Hives Sales YoY Growth (2021-2032) & (K Units) Figure 31. Anxiety Disorders Image Figure 32. Global Anxiety Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Doxepin Hydrochloride Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Doxepin Hydrochloride Market Share by Application 2025 VS 2032 Figure 35. North America Doxepin Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 36. North America Doxepin Hydrochloride Sales Market Share in Value by Application in 2025 Figure 37. Europe Doxepin Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 38. Europe Doxepin Hydrochloride Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Doxepin Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Doxepin Hydrochloride Sales Market Share in Value by Application in 2025 Figure 41. Latin America Doxepin Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Doxepin Hydrochloride Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Doxepin Hydrochloride Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Doxepin Hydrochloride Sales Market Share in Value by Application in 2025 Figure 45. North America Doxepin Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Doxepin Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Doxepin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Doxepin Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Doxepin Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Doxepin Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Doxepin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Doxepin Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Doxepin Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Doxepin Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Doxepin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Doxepin Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Doxepin Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Doxepin Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Doxepin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Doxepin Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Doxepin Hydrochloride Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Doxepin Hydrochloride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Doxepin Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Doxepin Hydrochloride Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Doxepin Hydrochloride Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Doxepin Hydrochloride Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 25mg
  • 50mg
Applications
  • Major Depressive Disorder
  • Trouble Sleeping
  • Chronic Hives
  • Anxiety Disorders
Companies covered
  • Ajanta Pharma
  • Amneal Pharms
  • Aurobindo Pharma
  • Boehringer Ingelheim
  • Elorac
  • Mylan Pharms
  • Par Pharm
  • Winston Pharmaceuticals
  • Hongsu Pharmaceutical
  • Qingping Pharmaceutical
  • Zhongxi Sunve Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Doxepin Hydrochloride Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Doxepin Hydrochloride Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Doxepin Hydrochloride Market by Type
  6. 1.3.1 10mg
  7. 1.3.2 25mg
  8. 1.3.3 50mg
  9. 1.4 Global Doxepin Hydrochloride Market Size by Type
  10. 1.4.1 Global Doxepin Hydrochloride Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Doxepin Hydrochloride Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Doxepin Hydrochloride Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Doxepin Hydrochloride Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Doxepin Hydrochloride Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Doxepin Hydrochloride Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Doxepin Hydrochloride Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Doxepin Hydrochloride Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Doxepin Hydrochloride Industry Trends
  2. 2.2 Doxepin Hydrochloride Industry Drivers
  3. 2.3 Doxepin Hydrochloride Industry Opportunities and Challenges
  4. 2.4 Doxepin Hydrochloride Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Doxepin Hydrochloride Revenue (2021-2026)
  2. 3.2 Global Top Players by Doxepin Hydrochloride Sales (2021-2026)
  3. 3.3 Global Top Players by Doxepin Hydrochloride Price (2021-2026)
  4. 3.4 Global Doxepin Hydrochloride Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Doxepin Hydrochloride Major Company Production Sites & Headquarters
  6. 3.6 Global Doxepin Hydrochloride Company, Product Type & Application
  7. 3.7 Global Doxepin Hydrochloride Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Doxepin Hydrochloride Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Doxepin Hydrochloride Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Doxepin Hydrochloride Tier 1, Tier 2, and Tier 3
4 Doxepin Hydrochloride Regional Status and Outlook
  1. 4.1 Global Doxepin Hydrochloride Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Doxepin Hydrochloride Historic Market Size by Region
  3. 4.2.1 Global Doxepin Hydrochloride Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Doxepin Hydrochloride Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Doxepin Hydrochloride Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Doxepin Hydrochloride Forecasted Market Size by Region
  7. 4.3.1 Global Doxepin Hydrochloride Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Doxepin Hydrochloride Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Doxepin Hydrochloride Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Doxepin Hydrochloride by Application
  1. 5.1 Doxepin Hydrochloride Market by Application
  2. 5.1.1 Major Depressive Disorder
  3. 5.1.2 Trouble Sleeping
  4. 5.1.3 Chronic Hives
  5. 5.1.4 Anxiety Disorders
  6. 5.2 Global Doxepin Hydrochloride Market Size by Application
  7. 5.2.1 Global Doxepin Hydrochloride Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Doxepin Hydrochloride Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Doxepin Hydrochloride Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Doxepin Hydrochloride Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Doxepin Hydrochloride Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Doxepin Hydrochloride Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Doxepin Hydrochloride Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Doxepin Hydrochloride Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ajanta Pharma
  2. 6.1.1 Ajanta Pharma Company Information
  3. 6.1.2 Ajanta Pharma Business Overview
  4. 6.1.3 Ajanta Pharma Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ajanta Pharma Doxepin Hydrochloride Product Portfolio
  6. 6.1.5 Ajanta Pharma Recent Developments
  7. 6.2 Amneal Pharms
  8. 6.2.1 Amneal Pharms Company Information
  9. 6.2.2 Amneal Pharms Business Overview
  10. 6.2.3 Amneal Pharms Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amneal Pharms Doxepin Hydrochloride Product Portfolio
  12. 6.2.5 Amneal Pharms Recent Developments
  13. 6.3 Aurobindo Pharma
  14. 6.3.1 Aurobindo Pharma Company Information
  15. 6.3.2 Aurobindo Pharma Business Overview
  16. 6.3.3 Aurobindo Pharma Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aurobindo Pharma Doxepin Hydrochloride Product Portfolio
  18. 6.3.5 Aurobindo Pharma Recent Developments
  19. 6.4 Boehringer Ingelheim
  20. 6.4.1 Boehringer Ingelheim Company Information
  21. 6.4.2 Boehringer Ingelheim Business Overview
  22. 6.4.3 Boehringer Ingelheim Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Boehringer Ingelheim Doxepin Hydrochloride Product Portfolio
  24. 6.4.5 Boehringer Ingelheim Recent Developments
  25. 6.5 Elorac
  26. 6.5.1 Elorac Company Information
  27. 6.5.2 Elorac Business Overview
  28. 6.5.3 Elorac Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Elorac Doxepin Hydrochloride Product Portfolio
  30. 6.5.5 Elorac Recent Developments
  31. 6.6 Mylan Pharms
  32. 6.6.1 Mylan Pharms Company Information
  33. 6.6.2 Mylan Pharms Business Overview
  34. 6.6.3 Mylan Pharms Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mylan Pharms Doxepin Hydrochloride Product Portfolio
  36. 6.6.5 Mylan Pharms Recent Developments
  37. 6.7 Par Pharm
  38. 6.7.1 Par Pharm Company Information
  39. 6.7.2 Par Pharm Business Overview
  40. 6.7.3 Par Pharm Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Par Pharm Doxepin Hydrochloride Product Portfolio
  42. 6.7.5 Par Pharm Recent Developments
  43. 6.8 Winston Pharmaceuticals
  44. 6.8.1 Winston Pharmaceuticals Company Information
  45. 6.8.2 Winston Pharmaceuticals Business Overview
  46. 6.8.3 Winston Pharmaceuticals Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Winston Pharmaceuticals Doxepin Hydrochloride Product Portfolio
  48. 6.8.5 Winston Pharmaceuticals Recent Developments
  49. 6.9 Hongsu Pharmaceutical
  50. 6.9.1 Hongsu Pharmaceutical Company Information
  51. 6.9.2 Hongsu Pharmaceutical Business Overview
  52. 6.9.3 Hongsu Pharmaceutical Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hongsu Pharmaceutical Doxepin Hydrochloride Product Portfolio
  54. 6.9.5 Hongsu Pharmaceutical Recent Developments
  55. 6.10 Qingping Pharmaceutical
  56. 6.10.1 Qingping Pharmaceutical Company Information
  57. 6.10.2 Qingping Pharmaceutical Business Overview
  58. 6.10.3 Qingping Pharmaceutical Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Qingping Pharmaceutical Doxepin Hydrochloride Product Portfolio
  60. 6.10.5 Qingping Pharmaceutical Recent Developments
  61. 6.11 Zhongxi Sunve Pharmaceutical
  62. 6.11.1 Zhongxi Sunve Pharmaceutical Company Information
  63. 6.11.2 Zhongxi Sunve Pharmaceutical Business Overview
  64. 6.11.3 Zhongxi Sunve Pharmaceutical Doxepin Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Zhongxi Sunve Pharmaceutical Doxepin Hydrochloride Product Portfolio
  66. 6.11.5 Zhongxi Sunve Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Doxepin Hydrochloride Sales by Country
  2. 7.1.1 North America Doxepin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Doxepin Hydrochloride Sales by Country (2021-2026)
  4. 7.1.3 North America Doxepin Hydrochloride Sales Forecast by Country (2027-2032)
  5. 7.2 North America Doxepin Hydrochloride Market Size by Country
  6. 7.2.1 North America Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Doxepin Hydrochloride Market Size by Country (2021-2026)
  8. 7.2.3 North America Doxepin Hydrochloride Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Doxepin Hydrochloride Sales by Country
  2. 8.1.1 Europe Doxepin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Doxepin Hydrochloride Sales by Country (2021-2026)
  4. 8.1.3 Europe Doxepin Hydrochloride Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Doxepin Hydrochloride Market Size by Country
  6. 8.2.1 Europe Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Doxepin Hydrochloride Market Size by Country (2021-2026)
  8. 8.2.3 Europe Doxepin Hydrochloride Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Doxepin Hydrochloride Sales by Country
  2. 9.1.1 Asia-Pacific Doxepin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Doxepin Hydrochloride Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Doxepin Hydrochloride Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Doxepin Hydrochloride Market Size by Country
  6. 9.2.1 Asia-Pacific Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Doxepin Hydrochloride Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Doxepin Hydrochloride Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Doxepin Hydrochloride Sales by Country
  2. 10.1.1 South America Doxepin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Doxepin Hydrochloride Sales by Country (2021-2026)
  4. 10.1.3 South America Doxepin Hydrochloride Sales Forecast by Country (2027-2032)
  5. 10.2 South America Doxepin Hydrochloride Market Size by Country
  6. 10.2.1 South America Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Doxepin Hydrochloride Market Size by Country (2021-2026)
  8. 10.2.3 South America Doxepin Hydrochloride Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Doxepin Hydrochloride Sales by Country
  2. 11.1.1 Middle East and Africa Doxepin Hydrochloride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Doxepin Hydrochloride Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Doxepin Hydrochloride Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Doxepin Hydrochloride Market Size by Country
  6. 11.2.1 Middle East and Africa Doxepin Hydrochloride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Doxepin Hydrochloride Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Doxepin Hydrochloride Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Doxepin Hydrochloride Value Chain Analysis
  2. 12.1.1 Doxepin Hydrochloride Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Doxepin Hydrochloride Production Mode & Process
  7. 12.2 Doxepin Hydrochloride Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Doxepin Hydrochloride Distributors
  10. 12.2.3 Doxepin Hydrochloride Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst